Filings
Finds words inside filing documents. Searching Transcode Therapeutics, Inc.'s filings · 54 documents indexed.
6 documents · 40 matches
-
RNAZ Transcode Therapeutics, Inc. 10-Q 2026-05-15
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations
material weaknesses in our internal control over financial reporting. If we are unable to remediate these material weaknesses, or if we identify6 matches in this document -
RNAZ Transcode Therapeutics, Inc. 10-Q 2026-08-14
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations
material weaknesses in our internal control over financial reporting. If we are unable to remediate these material weaknesses, or if we identify5 matches in this document -
RNAZ Transcode Therapeutics, Inc. 10-K 2026-04-15
Item 1A. Risk Factors
material weaknesses we have identified or avoid potential future material weaknesses. If the steps we take do not correct the material16 matches in this document -
RNAZ Transcode Therapeutics, Inc. 10-Q 2025-11-14
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations
material weaknesses in our internal control over financial reporting. If we are unable to remediate these material weaknesses, or if we identify5 matches in this document -
RNAZ Transcode Therapeutics, Inc. 10-Q 2025-08-14
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations
material weaknesses in our internal control over financial reporting. If we are unable to remediate these material weaknesses, or if we identify4 matches in this document -
RNAZ Transcode Therapeutics, Inc. 10-Q 2025-05-14
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations
material weaknesses in our internal control over financial reporting. If we are unable to remediate these material weaknesses, or if we identify4 matches in this document
Page 1 of 1 · 6 documents